Sotac Pharmaceuticals Current Share Price | Sotac Pharmaceuticals Stock Screener
SOTAC
Pharmaceuticals
Sotac Pharmaceuticals Current Stock Price Today
Track the current Sotac Pharmaceuticals share price and stock price live with TickJournal's free stock screener.
Browse SOTAC cash flow statement to support your investment research.
Use the Sotac Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sotac Pharmaceuticals Market Cap
₹99.51 Cr.
SOTAC P/E Ratio (TTM)
17.25
Sotac Pharmaceuticals P/B Ratio
1.69
EPS (TTM)
₹5.22
Dividend Yield
0.22%
Debt to Equity
0.70
SOTAC 52 Week High
-
Sotac Pharmaceuticals 52 Week Low
-
Operating Margin
8.00%
Profit Margin
3.57%
SOTAC Revenue (TTM)
₹28.00
EBITDA
₹3.00
Net Income
₹1.00
Total Assets
₹134.00
Total Equity
₹59.00
Sotac Pharmaceuticals Current Share Price Chart
Track the current Sotac Pharmaceuticals share price and stock price with an interactive chart. Analyse SOTAC price trends, trading volume, historical performance, and volatility across different timeframes — the complete Sotac Pharmaceuticals stock quote in one place.
Sotac Pharmaceuticals Company Profile - Fundamental Screener
Screen Sotac Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SOTAC shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0O2D01012
Sotac Pharmaceuticals Balance Sheet Screener
Screen SOTAC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 134 | 124 | 105 | 74 | 35 | 30 |
| Current Assets | 78 | 70 | 61 | 47 | 17 | 14 |
| Fixed Assets | 50 | 49 | 36 | 26 | 17 | 16 |
| Liabilities | ||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 11 | 14 | 12 | 8 | 9 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 59 | 58 | 49 | 20 | 3 | 5 |
| Share Capital | 11 | 11 | 11 | 8 | 2 | 2 |
| Reserves & Surplus | 48 | 42 | 34 | 2 | 0 | 1 |
Sotac Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Sotac Pharmaceuticals income statement and profit fundamentals.
Analyze SOTAC quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sotac Pharmaceuticals share price evaluation.
| Item | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28 | 26 | 27 | 26 | 27 | 25 | 18 | 20 | 41 |
| Expenses | 25 | 23 | 25 | 23 | 25 | 23 | 16 | 18 | 36 |
| EBITDA | 3 | 3 | 2 | 3 | 2 | 3 | 3 | 2 | 4 |
| Operating Profit % | 8.00% | 9.00% | 4.00% | 10.00% | 8.00% | 9.00% | 13.00% | 9.00% | 9.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 |
| Profit Before Tax | 1 | 1 | 0 | 2 | 1 | 2 | 1 | 1 | 2 |
| Tax | 1 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Net Profit | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | 0.42 | 1.32 | 1.49 | 0.82 | 0.58 | 1.01 | 1.58 | 0.29 | 4.41 |
Sotac Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SOTAC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2021-March | 2020-March |
|---|---|---|---|---|---|
| Operating Activities | -4 | -16 | 8 | 0 | 0 |
| Investing Activities | -14 | -20 | -12 | -3 | -12 |
| Financing Activities | 16 | 30 | 13 | 3 | 11 |
| Net Cash Flow | -2 | -6 | 10 | 0 | 0 |
Sotac Pharmaceuticals Shareholding Pattern Screener
See Sotac Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Sotac Pharmaceuticals promoter holding and ownership changes for SOTAC on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Apr | 2023-Sept |
|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.85% | 72.85% | 72.85% | 72.85% | 72.85% | 72.85% | 72.85% |
| FII Holding | 16.79% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.52% | 4.70% | 5.13% | 5.82% | 6.01% | 8.19% | 5.32% |
| Other Holding | 3.84% | 22.45% | 22.02% | 21.33% | 21.14% | 18.96% | 21.83% |
| Shareholder Count | 221 | 243 | 240 | 245 | 251 | 784 | 255 |
Sotac Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Sotac Pharmaceuticals dividend history with payout and yield data.
View Sotac Pharmaceuticals dividend details including ex-dates and amounts for SOTAC stock.
Sotac Pharmaceuticals Stock Index Membership
See which indices include Sotac Pharmaceuticals stock.
Check SOTAC index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sotac Pharmaceuticals Market Events Screener - Corporate Actions
Get Sotac Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Sotac Pharmaceuticals stock events that may affect SOTAC share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | -0.27% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -0.65% |
| 2025-09-19 | 2025-09-19 | Dividend | ₹ 0.10 /share | 1.16% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -0.21% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -4.97% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | -12.52% |
Sotac Pharmaceuticals Competitors Screener - Peer Comparison
Screen SOTAC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 443,181 | 36.34 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 241,776 | 83.41 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 182,101 | 85.57 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 111,662 | 23.87 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,883 | 32.76 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 101,558 | 95.29 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,453 | 30.15 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 94,724 | 25.82 | 34,145 | 5.56% | 3,503 | 53.00 |
| Mankind Pharma | 93,796 | 45.72 | 14,636 | 14.85% | 1,938 | 37.66 |
| Lupin | 93,545 | 16.93 | 29,039 | 26.75% | 5,356 | 24.64 |
Sotac Pharmaceuticals Company Announcements - News Screener
Screen SOTAC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.